Pharmocann Global Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Pharmocann Global has been growing earnings at an average annual rate of 15.6%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been declining at an average rate of 9.1% per year.

Wichtige Informationen

15.6%

Wachstumsrate der Gewinne

40.5%

EPS-Wachstumsrate

Pharmaceuticals Wachstum der Industrie35.1%
Wachstumsrate der Einnahmen-9.1%
Eigenkapitalrendite-4,587.4%
Netto-Marge-76.1%
Letzte Ertragsaktualisierung30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Mar 30
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Feb 04
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 31
Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Nov 26
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Aufschlüsselung der Einnahmen und Ausgaben

Wie Pharmocann Global Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

TASE:PMCN-M Einnahmen, Ausgaben und Erträge (ILS Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 2413-1080
31 Mar 2414-1080
31 Dec 2314-1080
30 Sep 2311-1260
30 Jun 2312-1871
31 Mar 2317-24101
31 Dec 2223-25131
30 Sep 2224-23121
30 Jun 2225-20131
31 Mar 2228-16151
31 Dec 2129-19151
30 Sep 2131-14151
30 Jun 2132-7151
31 Mar 21312131
31 Dec 20284131
30 Sep 20266111
30 Jun 20265101
31 Mar 2021-2591
31 Dec 1921-4661
30 Sep 1918-4660
30 Jun 1917-4640
31 Mar 1916-2040
31 Dec 1815630
31 Dec 1712230
31 Dec 169120

Qualität der Erträge: PMCN-M is currently unprofitable.

Wachsende Gewinnspanne: PMCN-M is currently unprofitable.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: PMCN-M is unprofitable, but has reduced losses over the past 5 years at a rate of 15.6% per year.

Beschleunigtes Wachstum: Unable to compare PMCN-M's earnings growth over the past year to its 5-year average as it is currently unprofitable

Erträge im Vergleich zur Industrie: PMCN-M is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (7.1%).


Eigenkapitalrendite

Hohe Eigenkapitalrendite: PMCN-M has a negative Return on Equity (-4587.44%), as it is currently unprofitable.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren